Short Interest in Cibus, Inc. (NASDAQ:CBUS) Increases By 33.3%

Cibus, Inc. (NASDAQ:CBUS) saw a significant growth in short interest in June. As of June 15th, there was short interest totalling 878,800 shares, a growth of 33.3% from the May 31st total of 659,100 shares. Approximately 5.8% of the shares of the stock are sold short. Based on an average daily trading volume, of 111,500 shares, the short-interest ratio is presently 7.9 days.

Institutional Trading of Cibus

A number of institutional investors and hedge funds have recently bought and sold shares of CBUS. Gladius Capital Management LP bought a new stake in shares of Cibus in the 4th quarter valued at about $56,000. Indie Asset Partners LLC lifted its stake in shares of Cibus by 30.1% in the fourth quarter. Indie Asset Partners LLC now owns 16,929 shares of the company’s stock worth $332,000 after acquiring an additional 3,921 shares during the period. FMR LLC boosted its holdings in Cibus by 0.4% in the third quarter. FMR LLC now owns 2,496,152 shares of the company’s stock valued at $45,480,000 after acquiring an additional 8,763 shares during the last quarter. Citigroup Inc. acquired a new stake in Cibus during the 3rd quarter valued at approximately $199,000. Finally, Cerity Partners LLC bought a new position in Cibus during the 4th quarter worth approximately $323,000. 33.81% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, HC Wainwright restated a “buy” rating and set a $25.00 price objective on shares of Cibus in a research report on Friday, May 10th.

Cibus Stock Performance

Shares of Cibus stock traded up $0.36 on Friday, hitting $9.85. The stock had a trading volume of 2,172,591 shares, compared to its average volume of 185,199. The stock has a 50 day moving average of $14.04 and a 200 day moving average of $16.81. The firm has a market capitalization of $212.27 million, a P/E ratio of -0.54 and a beta of 1.92. Cibus has a twelve month low of $8.31 and a twelve month high of $24.61.

Cibus (NASDAQ:CBUS) last announced its quarterly earnings results on Thursday, May 9th. The company reported ($1.12) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.01) by ($0.11). The business had revenue of $0.55 million during the quarter, compared to analyst estimates of $0.40 million. Cibus had a negative net margin of 12,313.28% and a negative return on equity of 23.33%. During the same quarter last year, the company posted ($5.45) earnings per share. Equities analysts expect that Cibus will post -3.22 earnings per share for the current year.

Cibus Company Profile

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.